Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CTXRCTXR
7 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CITIUS PHARMACEUTICALS INC

NORTHERN TRUST CORP holds 62,742 shares of CTXR (CITIUS PHARMACEUTICALS INC), worth $37,928 as of 2026-Q2. The position was increased (+42.7% shares).

Current Value

$37,928

Current Shares

62,742

Total Value Change

-$13,164

Total Shares Change

+49,969

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
62,742
+42.7%
$37,9280.0%$0.61
18
2026-Q1
Unchanged
43,974
0.0%
$39,5770.0%$0.74
0
2025-Q4
Increased
43,974
+62.7%
$34,1680.0%$0.78
20
2025-Q3
Increased
27,025
+88.0%
$33,5110.0%$1.18
21
2025-Q2
Decreased
14,373
-5.3%
$22,8530.0%$1.53
0
2025-Q1
Increased
15,173
+18.8%
$22,6080.0%$1.55
15
2024-Q4
New
12,773
-
$51,0920.0%$3.91
31

Other major holders of CTXR: VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used